Feb 4 (Reuters) - Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development. The ...

Biopharmaceuticals (biologics) are complex drugs made from living sources, not chemical processes. The government is planning ...

Pharma shares were trading higher on Sunday after Finance Minister Nirmala Sitharaman in her Budget speech said the government would unveil as a Bio Pharma Shakti scheme with an outlay of Rs 10,000 ...

As Samsung Biologics’ contract manufacturing business continues to fire on all cylinders, the CDMO has earned a unique ...

DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...

There's no need to hurry in buying this biotech stock.

Union Finance Minister Nirmala Sitharaman made one of the most significant announcements of Budget 2026 by unveiling ‘Biopharma Shakti', a flagship initiative with an outlay of ₹10,000 crore over the ...

Non-communicable diseases, geriatric care and manufacturing of bio-pharmaceuticals received a mention in Budget 2026, aside ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

The MarketWatch News Department was not involved in the creation of this content. HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter ...

Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for ...

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...